Form 4 for MANE Veradermics, Inc
Accepted 2026-08-21 18:11:27 ET · period of report 2026-08-19 · accession 0000899140-26-000947 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-08-21 18:11 | 2026-08-19 | MANE | MONTANOVA CAPITAL, LLC | Dir | S - Sale+OE | $107.25 | -750.0K | 461.0K | -62% | -$80.44M |
| DMI | 2026-08-21 18:11 | 2026-08-20 | MANE | MONTANOVA CAPITAL, LLC | Dir | X - OptEx | — | +300.0K | 612.0K | +96% | — |
| DMI | 2026-08-21 18:11 | 2026-08-20 | MANE | MONTANOVA CAPITAL, LLC | Dir | X - OptEx | $0.00 | -300.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.00001 per share | 2026-08-19 | S | D | 690,601 | $107.25 | 2,957,937 | I See footnotes | — | — | (F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F2) Notes are included on Exhibit 99.1. |
| 2 | Common | Common stock, par value $0.00001 per share | 2026-08-19 | S | D | 59,399 | $107.25 | 461,033 | I See footnotes | — | — | (F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F3) Notes are included on Exhibit 99.1. |
| 3 | Common | Common stock, par value $0.00001 per share | 2026-08-20 | X | A | 149,000 | — | 3,106,937 | I See footnotes | — | — | (F4) Notes are included on Exhibit 99.1. (F6) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F4) Notes are included on Exhibit 99.1. |
| 4 | Common | Common stock, par value $0.00001 per share | 2026-08-20 | X | A | 151,000 | — | 612,033 | I See footnotes | — | — | (F5) Notes are included on Exhibit 99.1. (F6) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F5) Notes are included on Exhibit 99.1. |
| 5 | Derivative | Pre-Funded Warrants | 2026-08-20 | X | D | 149,000 | $0.00 | 0 | I See footnotes | — · — to — | 149,000 Common Stock | (F6) Notes are included on Exhibit 99.1. (F4) Notes are included on Exhibit 99.1. (F7) Notes are included on Exhibit 99.1. (F8) Notes are included on Exhibit 99.1. (F7) Notes are included on Exhibit 99.1. (F7) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F4) Notes are included on Exhibit 99.1. |
| 6 | Derivative | Pre-Funded Warrants | 2026-08-20 | X | D | 151,000 | $0.00 | 0 | I See footnotes | — · — to — | 151,000 Common Stock | (F6) Notes are included on Exhibit 99.1. (F5) Notes are included on Exhibit 99.1. (F7) Notes are included on Exhibit 99.1. (F8) Notes are included on Exhibit 99.1. (F7) Notes are included on Exhibit 99.1. (F7) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. (F5) Notes are included on Exhibit 99.1. |